Possible scenario
Enforcement Broadens
25% Chance
The CVS payment becomes a template for additional Department of Justice scrutiny of large pharmacy chains and legacy dispensing controls. The read-through is negative but limited because opioid liabilities have been known for years and many companies already strengthened compliance programs.
Secondary impacts
- Healthcare -0.5%
Tickers
- CVS-3.1%
Portfolio impact
S&P 500-0.1%
Each figure is the modeled move of the S&P 500 if the outcome occurs. For information only. Not investment advice.
Keeping an eye on this scenario?
Tilt can alert you when its probability or impact shifts, or send you a recommendation when it crosses a threshold.